Alerts will be sent to your verified email
Verify Email
SPARC
|
Sun Pharma Adv. Res
|
Dishman Carbogen Amc
|
Zenotech Laboratorie
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-64.48 % | -0.61 % | 7.83 % |
|
5yr Avg Net Profit Margin
|
-361.01 % | -1.43 % | -17.58 % |
|
Price to Book
|
0.0 | 0.71 | 3.58 |
|
P/E
|
0.0 | 39.55 | 65.43 |
|
5yr Avg Cash Conversion Cycle
|
80.33 Days | 49.26 Days | 36.89 Days |
|
5yr Average Interest Coverage Ratio
|
-97.45 | 1.02 | -4.03 |
|
5yr Avg ROCE
|
208.61 % | 1.2 % | 7.95 % |
|
5yr Avg Operating Profit Margin
|
-357.39 % | 15.55 % | 4.66 % |
|
5 yr average Debt to Equity
|
-0.27 | 0.26 | 0.12 |
|
5yr CAGR Net Profit
|
9.0 % | n/a | n/a |
|
5yr Average Return on Assets
|
-68.32 % | -0.35 % | 7.07 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.67 % | 59.32 % | 68.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.42 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.7 % | -5.47 % | 0.0 |
|
Sun Pharma Adv. Res
|
Dishman Carbogen Amc
|
Zenotech Laboratorie
|
|---|